Sign inGet started

Kastenmayer James Paul

Insider CIK 1798800 · AGLE Interim CEO & General Counsel · VIE General Counsel · AVBP General Counsel

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AVBP ArriVent BioPharma, Inc. A Award deriv2026-02-022026-02-04130,000— $0130,000SEC↗
AVBP ArriVent BioPharma, Inc. A Award deriv2025-02-032025-02-14102,000— $0102,000SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2023-02-232023-02-24500,000— $0500,000SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2022-08-232022-08-25130,000— $0130,000SEC↗
VIE Viela Bio, Inc. D To issuer deriv2021-03-152021-03-1550,000— $00SEC↗
VIE Viela Bio, Inc. A Award deriv2020-01-142020-01-1550,000— $050,000SEC↗